Mastitis and Breast Abscess for Surgeons — Lactational Triage, Aspiration-First Drainage, Periductal Fistula Surgery and Granulomatous Restraint

The one-line answer

Mastitis is a clinical diagnosis managed by emptying the breast and continuing to feed; the abscess is its most common complication and is usually aspirated under ultrasound rather than incised; periductal disease with fistula needs terminal-duct excision plus smoking cessation; and granulomatous mastitis is a prolonged mimicker of cancer where steroid-based combination therapy beats steroids alone and local steroids beat systemic toxicity. The surgeon's error is never missing rarity; it is stopping feeds for mastitis, incising every abscess, draining a fistula without its ducts, and treating granulomatous disease as routine bacterial infection.^{[1][3][4][12]}

A 29-year-old breastfeeding mother with a tender febrile breast lump walks the whole topic in one patient: confirm clinical mastitis, keep her feeding with emptying and targeted anti-staphylococcal cover, aspirate under ultrasound if an abscess declares itself, culture every collection, and keep periductal and granulomatous pathways in mind only if she is not lactating, smokes, has a fistula, or the mass refuses to behave.^[1][16][20]

Lactational mastitis — clinical diagnosis, emptying first, feed through it

• Mastitis occurs in approximately 10 percent of U.S. mothers who are breastfeeding, and it can lead to the cessation of breastfeeding — so the first counsel is that feeding through treatment protects the feed itself.^[1]
• The diagnosis of mastitis is usually clinical, with patients presenting with focal tenderness in one breast accompanied by fever and malaise — image the uncertain or mass-like case, do not biopsy every hot breast.^[1]
• The risk of mastitis can be reduced by frequent, complete emptying of the breast and by optimizing breastfeeding technique — with lactation support as treatment, not reassurance alone.^[1]
• Continued breastfeeding should be encouraged in the presence of mastitis and generally does not pose a risk to the infant — and breastfeeding can usually continue in the presence of a treated abscess.^[1]
• When antibiotics are needed, those effective against Staphylococcus aureus (e.g., dicloxacillin, cephalexin) are preferred — with methicillin-resistant cover considered as resistant organisms become a more common cause of mastitis.^[1]
• The guideline frame is explicit that protocols exist to manage common medical problems that may impact breastfeeding success: a central goal of the Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success.^[20]
• Breast abscess is the most common complication of mastitis — and it can be prevented by early treatment of mastitis and continued breastfeeding, with surgical drainage or needle aspiration needed once an abscess occurs.^[1]

Breast abscess — aspiration first, incision by indication

• A breast abscess is a localised accumulation of infected fluid in breast tissue — and abscesses are commonly treated with antibiotics, incision and drainage (I&D) or ultrasound-guided needle aspiration, but there is no consensus on the optimal treatment.^[2]
• The modern framework sets aspiration first: across seven studies, US-guided needle aspiration demonstrated high resolution rates (85-92%) with shorter healing times and improved patient-reported outcomes compared with I&D — while surgical drainage remains the preferred treatment for collections over 5 cm, multiloculated or recurrent abscesses, particularly in non-lactational cases.^[3]
• The Cochrane caution stays on the consent form: treatment failure was more common with needle aspiration than I&D (RR 16.12 across two studies, n = 115, low quality evidence), all abscesses in the I&D group were successfully treated, and there is insufficient evidence to declare aspiration more effective than I&D overall — so promise repeatability, not infallibility.^[2]
• The randomised detail favours the minimally invasive path where it succeeds: in 44 patients randomised 23 to aspiration and 21 to drainage, there was no statistical difference in treatment failure, fistula formation or recurrence, but healing period, scar formation, continuation of breastfeeding and clinical resolution all differed significantly favouring aspiration, with significantly less post-intervention pain in the aspiration arm.^[5]
• In that trial, patients with lactational abscesses were encouraged to breastfeed from either breast, and the antibiotic was given for 10 days to all the patients — feed through drainage, and cover every drained collection.^[5]
• The Ugandan trial grounds feasibility and cost: 65 abscesses randomised 33 to ultrasound-guided aspiration and 32 to incision and drainage showed no difference in healing rate (log-rank P = 0.63), incision and drainage was more costly than ultrasound-guided aspiration (cost-effective ratio 2.85), and aspiration is feasible and cost effective for lactating and non-lactating abscesses up to 5 cm in the immune-competent patient.^[6]
• The 64-patient comparison adds healing numbers: sixty-four patients randomised to incision and drainage versus needle aspiration showed a significant mean difference in healing time (P = 0.001), with 93.3 per cent healed with aspiration against 76.6 per cent with drainage (P = 0.033) — ultrasound-guided aspiration with judicious antibiotics beating drainage in that cohort.^[7]
• The North Indian cohort sets the recurrence trade honestly: of 118 patients (60 incision and drainage, 58 ultrasound-guided aspiration), recurrence was more frequent with aspiration (12.0% versus 5.0%) yet most aspiration recurrences were managed with repeat aspirations, while the drainage arm carried longer illness (10.36 versus 8.06 days, p = 0.012) with more fistulisation and scarring and worse cosmetic outcomes with more disfigurement.^[8]
• The breastfeeding cohort removes size as an absolute bar: in 64 breastfeeding mothers with abscess, all received oral antibiotic treatment, 71.9% underwent fine-needle aspiration including abscesses greater than 5 cm, and none required I&D — with aspiration as an outpatient, repeatable, cosmetically clean path that avoids dividing ducts and separates mother and child least.^[17]
• Most abscesses in that cohort clustered early after birth: most developed within the first 100 days (68.8% within the first 60 days) after delivery — so the febrile tender lump at six weeks postpartum is an abscess until proven otherwise.^[17]
• For large lactational collections there is a catheter middle path: twelve puerperal single abscesses larger than 5 cm treated with ultrasound-guided percutaneous catheter placement plus hydrostatic-pressure irrigation and oral antibiotics were all completely successful without conversion to open drainage, with recovery in 5 to 16 days, no major complications, and no recurrence in three-month follow-up.^[9]
• The size consensus behind that result states the fences explicitly: lesions under 3 cm suit aspiration alone, lesions over 3 cm require catheter drainage, lesions under 5 cm suit ultrasound-guided therapy, and lesions over 5 cm, whether multi-loculated or longstanding, require surgical incision and drainage — the ladder the catheter series extends rather than repeals.^[9]
• The French guideline draws the same 5 cm line conservatively: for abscesses under 5 cm a suction or drainage needle with antibiotic therapy is recommended (grade C), while for abscesses over 5 cm there is no evidence to recommend first surgery or suction and drainage — so counsel the large abscess as judgement, not protocol.^[18]

Microbiology — culture every abscess, cover MRSA where it dominates

• Breast abscesses are a common complication of mastitis, traditionally caused by methicillin-sensitive Staphylococcus aureus — but recent global reports indicate rising methicillin-resistant disease, so cover follows culture, not habit.^[16]
• The Karachi series quantifies the shift: of 366 culture-positive breast abscesses, 326 (89.0%) yielded Staphylococcus aureus, of which 274 were MRSA representing 74.5% of all isolates — one of the highest documented MRSA rates worldwide with clear post-2020 dominance.^[16]
• In that series the mean age of MRSA patients was 29.4 years with 88.7% lactational disease, and key risk factors were prior antibiotic exposure (63.0%), recent hospitalization (55.9%), diabetes (18.6%) and previous abscess (14.4%).^[16]
• Susceptibilities stayed workable: all MRSA isolates were vancomycin-susceptible, with low resistance to clindamycin (11.7%) and trimethoprim-sulfamethoxazole (9.8%) — and empirical clindamycin was used in just over half the cohort.^[16]
• Management in that high-MRSA setting stayed aspiration-first: initial ultrasound-guided aspiration was performed in 60.2%, with 20.6% requiring subsequent incision and drainage — with complete resolution in all followed patients, recurrence of only 3.3%, and 91.4% of lactational cases successfully resuming breastfeeding.^[16]
• The rule the authors draw travels: in high-prevalence settings, empirical therapy must cover MRSA, and routine culture with sensitivity testing is strongly recommended — with ultrasound-guided aspiration remaining first-line and continued breastfeeding safe and encouraged after treatment.^[16]
• The breastfeeding abscess cohort reinforces the culture habit: all patients received oral antibiotic treatment with microbiologic testing of milk or abscess material, and the authors recommend antibiotic therapy targeted at the methicillin-resistant Staphylococcus aureus identified plus needle aspiration where feasible.^[17]
• Satisfaction and feeding favour the needle where it works: the Cochrane review found one 60-woman study reporting greater satisfaction with aspiration than I&D, and one study reporting more continued breastfeeding with aspiration (RR 2.89) against another showing no clear difference — so quote both, and let the patient's feeding priority decide.^[2]

Periductal disease and mammary fistula — ducts, smoke and definitive excision

• Peripheral nonlactational abscesses behave like other soft tissue abscesses and resolve with drainage and antibiotics — the non-lactating peripheral lump is drained, covered and followed, not widely excised.^[4]
• Subareolar disease is a different operation: subareolar abscesses tend to recur or develop fistulae between obstructed ducts and the areolar border, usually in women in their thirties with smoking history or congenitally cleft nipples — with keratin plugging from squamous metaplasia obstructing terminal ducts as the underlying cause.^[4]
• Successful resolution requires excision of the terminal ducts in and just below the nipple with correction of nipple deformity where present — drainage plus antibiotics without duct excision is the recurrence booked.^[4]
• The Hadfield series proves the point in smokers: eighteen women with recurrent periductal mastitis and fistula underwent fistulectomy, mean age 42 years with 17 of 18 smoking more than 10 cigarettes per day — with squamous metaplasia always present, no postoperative events, cosmetic satisfaction, and only 2 recurrences at 36 months median follow-up, neither quitter among the recurred.^[10]
• Recurrent periductal mastitis is a benign disorder that often features a mammary fistula running between periareolar skin and the ductal system, and its management is controversial precisely because of the high recurrence rate — which is why the authors conclude the best treatment combines total excision of the affected duct and the fistulous tract.^[10]
• Smoking cessation is prescribed, not suggested: due to the important role of smoking in this disease, it is important to encourage patients to stop smoking — all but one patient were heavy smokers at presentation.^[10]
• The fistula classification sharpens selection: sixteen women with eighteen fistulae (mean age 36.5 years, average 1.8 prior abscesses, nipple abnormalities in 32%) showed periductal mastitis in ten, granulomatous mastitis in five and tuberculous mastitis in one — with coagulase-negative staphylococci predominating and eleven (69%) undergoing total ductal-system plus tract excision with negligible morbidity and good cosmesis.^[11]
• Deep fistulae directly related to a diseased ductal system must be differentiated from superficial fistulae arising from subepidermal glands: deep periductal fistulae need total ductal-system excision with the tract under antibiotics for the lowest recurrence, while granulomatous fistulae deserve a trial of conservative treatment first.^[11]
• The French synthesis agrees on restraint outside infection: inflammatory mastitis may be primary or secondary to systemic disease, plasma-cell mastitis or ductal ectasia needs no treatment, and infectious periareolar abscess remains the most common non-puerperal abscess form.^[18]

Granulomatous mastitis — the cancer mimicker that rewards combination and locality

• Idiopathic granulomatous mastitis is a rare, benign, chronic inflammatory condition that can mimic inflammatory breast cancer and periductal mastitis — biopsy first, because the clinical eye cannot separate them.^[19]
• The 25-year comparison locates the patient: eighteen granulomatous cases against 133 periductal and 100 controls showed median age 36 versus 52 years for periductal disease, only 17% smokers versus 60% of periductal patients, 56% with birth in the last 5 years versus 5% of periductal patients — younger, recently parous, and not smoking-driven.^[19]
• The course humbles the surgeon: granulomatous disease ran 11 to 105 weeks and was not affected by any treatment modality in that series — so treatment should be supportive first, and recurrence after pregnancy is part of counsel with two such recurrences observed.^[19]
• The umbrella review sets the modern hierarchy: across six reviews (five conventional plus one network meta-analysis, 2017 to 2026), steroid-based combination therapy showed the most consistent favourable signal for recurrence reduction, with triple therapy of surgery plus local steroid injection plus systemic corticosteroids ranking most favourably — while systemic-steroid monotherapy and conservative-only approaches looked less favourable for long-term control.^[12]
• Local steroids specifically improve response with less toxicity: across eight trials with 613 patients, local administration (intralesional injection and topical ointment) improved response rate (RR 1.35) and lowered side effects versus systemic therapy (RR 0.24), with no difference in recurrence rate — the response-without-toxicity argument for going local.^[13]
• Steroids alone underperform combination: across twelve studies with 559 patients, steroid-only versus surgery-only recurrence showed no significant difference (RR 2.99, RD 0.14), while steroid-only versus steroids-plus-surgery showed significantly higher recurrence with steroids alone by risk difference (RD 0.28) — managing with only steroids may be less effective than steroids plus surgery.^[14]
• Equipoise remains honest elsewhere: across ten studies with 1,101 patients, conservative versus surgical protocols showed no significant difference in recurrence — so both approaches have appropriate efficacy and the choice turns on extent, deformity, fistula and patient tolerance rather than a recurrence trump card.^[15]
• The French line stays neutral for the same reason: for idiopathic granulomatous mastitis, steroid therapy or surgery may be indicated, without either method recommended over the other — state the options, do not anoint one.^[18]

Follow-up and exam traps

• Lactational follow-up means feeding plus review: continued emptying with technique correction, anti-staphylococcal cover when needed, and aspiration under ultrasound if fluctuation declares itself — because early treatment plus continued feeding prevents the abscess that fails the viva.^[1][2]
• Abscess follow-up is aspiration-first with fences: resolve most collections with ultrasound-guided aspiration and antibiotics, convert collections over 5 cm, multiloculated or recurrent disease (especially non-lactational) to surgery, and consider catheter-plus-irrigation for large lactational cavities — quoting 85 to 92% resolution with aspiration against higher failure and repeat-aspiration reality.^[3][9]
• Microbiology follow-up is culture-led: sample milk or pus in every abscess, cover MRSA empirically only where prevalence justifies it, and resume feeding after treatment — with 91.4% resumption achievable even in a 74.5%-MRSA cohort.^[16][17]
• Periductal follow-up runs through smoking and ducts: excise the affected duct plus fistulous tract (Hadfield) for recurrent subareolar disease with nipple correction where needed, classify deep versus superficial fistulae, and make cessation the discharge prescription — the two recurrences that kept smoking are the viva's trap.^[10][11]
• Granulomatous follow-up is long and local: expect an 11-to-105-week course that mimics cancer, favour steroid-based combination (ideally triple therapy) for recurrence control, use local steroids for response with fewer systemic effects, and counsel that conservative and surgical paths carry similar recurrence — so the plan is combination, locality and patience, not radicality.^{[12][13][15][19]}

References20ShowHide

1. [1]Spencer JP, et al. Management of mastitis in breastfeeding women. Am Fam Physician, 2008.PMID 18819238
2. [2]Irusen H, et al. Treatments for breast abscesses in breastfeeding women. Cochrane Database Syst Rev, 2015.PMID 26279276
3. [3]Scardina L, et al. Management of lactational and non-lactational breast abscesses: an evidence-based framework to support breast surgeon decision-making. Updates Surg, 2026.PMID 42334816
4. [4]Snider HC, et al. Management of Mastitis, Abscess, and Fistula. Surg Clin North Am, 2022.PMID 36335928
5. [5]Pal B, et al. A Randomized Controlled Trial Comparing Ultrasonography-Guided Needle Aspiration and Surgical Drainage for the Management of Breast Abscess. Cureus, 2023.PMID 38249226
6. [6]Chandika AB, et al. Ultrasound Guided Needle Aspiration versus Surgical Drainage in the management of breast abscesses: a Ugandan experience. BMC Res Notes, 2012.PMID 22226127
7. [7]Naeem M, et al. Comparison of incision and drainage against needle aspiration for the treatment of breast abscess. Am Surg, 2012.PMID 23089439
8. [8]Bhat OM, et al. Ultrasound-Guided Needle Aspiration vs. Surgical Incision and Drainage of Breast Abscesses: Our Experience at a Tertiary Care Centre in North India. Cureus, 2026.PMID 41815606
9. [9]Du Z, et al. Treatment of lactational breast abscesses with cavity diameter larger than 5 cm via combined ultrasonography-guided percutaneous catheter placement and hydrostatic pressure irrigation. J Obstet Gynaecol, 2022.PMID 34030591
10. [10]Taffurelli M, et al. Recurrent periductal mastitis: Surgical treatment. Surgery, 2016.PMID 27616631
11. [11]Almasad JK, et al. Mammary duct fistulae: classification and management. ANZ J Surg, 2006.PMID 16626355
12. [12]Yao S, et al. Therapeutic strategies for idiopathic granulomatous mastitis: an umbrella review of systematic reviews and meta-analyses. Front Med (Lausanne), 2026.PMID 42318409
13. [13]Zhang Q, et al. The Effect of Local Steroid Administration on Idiopathic Granulomatous Mastitis: A Systematic Review andMeta-Analysis. J Surg Res, 2024.PMID 38071781
14. [14]Godazandeh G, et al. Corticosteroids in idiopathic granulomatous mastitis: a systematic review and meta-analysis. Surg Today, 2021.PMID 33590327
15. [15]Zhou F, et al. Comparison of Conservative versus Surgical Treatment Protocols in Treating Idiopathic Granulomatous Mastitis: A Meta-Analysis. Breast Care (Basel), 2020.PMID 32982653
16. [16]Asif N, et al. Methicillin-Resistant Staphylococcus aureus breast abscesses: Risk factors and outcomes from a tertiary care center of a lower-middle-income country. Pak J Med Sci, 2026.PMID 42136789
17. [17]Pileri P, et al. Management of Breast Abscess during Breastfeeding. Int J Environ Res Public Health, 2022.PMID 35565158
18. [18]Laas E, et al. [Inflammatory and infectious breast mastitis outside of pregnancy and lactation: Guidelines]. J Gynecol Obstet Biol Reprod (Paris), 2015.PMID 26541563
19. [19]Al-Khaffaf B, et al. Idiopathic granulomatous mastitis: a 25-year experience. J Am Coll Surg, 2008.PMID 18222379
20. [20]Mitchell KB, et al. Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022. Breastfeed Med, 2022.PMID 35576513